Impact BioMedical Inc.
IBO
$0.8569
-$0.0731-7.86%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.67M | 2.00K | 2.00K | 1.00K | 201.00K |
Total Receivables | 142.00K | 263.00K | 331.00K | 331.00K | 300.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 365.00K | 42.00K | 2.00K | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 3.18M | 307.00K | 335.00K | 332.00K | 501.00K |
|
|||||
Total Current Assets | 3.18M | 307.00K | 335.00K | 332.00K | 501.00K |
Net Property, Plant & Equipment | 282.00K | 284.00K | 285.00K | 287.00K | 289.00K |
Long-term Investments | 25.09M | 25.09M | 25.09M | 25.09M | 25.09M |
Goodwill | 25.09M | 25.09M | 25.09M | 25.09M | 25.09M |
Total Other Intangibles | 18.09M | 18.37M | 18.64M | 18.92M | 19.20M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 59.00K | 67.00K | -- | -- | -- |
Total Assets | 46.70M | 44.12M | 44.36M | 44.63M | 45.08M |
|
|||||
Total Accounts Payable | 1.00M | 986.00K | 1.02M | 832.00K | 476.00K |
Total Accrued Expenses | 102.00K | 61.00K | 47.00K | 230.00K | 6.00K |
Short-term Debt | -- | 13.45M | 12.79M | 12.07M | 11.78M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 35.00K | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 1.14M | 14.50M | 13.86M | 13.14M | 12.27M |
|
|||||
Total Current Liabilities | 1.14M | 14.50M | 13.86M | 13.14M | 12.27M |
Long-Term Debt | 7.97M | -- | -- | -- | -- |
Short-term Debt | -- | 13.45M | 12.79M | 12.07M | 11.78M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 3.24M | 3.24M | 3.24M | 3.24M | 3.24M |
Total Liabilities | 12.34M | 17.73M | 17.09M | 16.37M | 15.50M |
|
|||||
Common Stock & APIC | 41.85M | 38.12M | 38.12M | 38.12M | 38.18M |
Retained Earnings | -10.56M | -14.81M | -13.92M | -12.96M | -11.67M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 31.29M | 23.31M | 24.20M | 25.16M | 26.52M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 60.00K | 60.00K | 60.00K | 60.00K | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 60.00K | 60.00K | 60.00K | 60.00K | -- |
|
|||||
Total Common Equity | 31.29M | 23.31M | 24.20M | 25.16M | 26.52M |
Total Preferred Equity | 60.00K | 60.00K | 60.00K | 60.00K | -- |
Total Minority Interest | 3.00M | 3.01M | 3.00M | 3.04M | 3.07M |
Total Equity | 34.35M | 26.38M | 27.26M | 28.26M | 29.58M |
|